#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4727374	Binding	Inhibition of beta-1,3-glucan synthase in Candida albicans MY1055 microsomal membrane using UDP-[3H]-glucose as substrate incubated for 2 hrs in presence of UTP by radioactivity-based assay	Candida albicans	30	ALA4725308	cell membrane format	Scientific Literature
2.	ALA4727375	Functional	Antifungal activity against Candida albicans MY1055 assessed as fungal growth inhibition measured after 24 hrs by liquid microdilution method	Candida albicans	30	ALA4725308	organism-based format	Scientific Literature
3.	ALA4727376	Functional	Antifungal activity against Aspergillus fumigatus MF5668 assessed as fungal growth inhibition measured after 24 hrs by liquid microdilution method	Aspergillus fumigatus	30	ALA4725308	organism-based format	Scientific Literature
4.	ALA4727377	ADME	AUC in po dosed mouse	Mus musculus	16	ALA4725308	organism-based format	Scientific Literature
5.	ALA4727378	ADME	Oral bioavailability in mouse	Mus musculus	16	ALA4725308	organism-based format	Scientific Literature
6.	ALA4727379	Functional	Antifungal activity against Candida albicans MY1055 infected in DBA/2 mouse model assessed as log change in colony forming units in kidney at 6.5 mg/kg, po bid for 2 days and measured after 4 days by TOKA	Candida albicans	19	ALA4725308	organism-based format	Scientific Literature
7.	ALA4727380	Functional	Antifungal activity against Candida albicans MY1055 infected in DBA mouse model assessed as log change in colony forming units in kidney at 12.5 mg/kg, po bid for 2 days and measured after 4 days by TOKA	Candida albicans	19	ALA4725308	organism-based format	Scientific Literature
8.	ALA4727381	Functional	Antifungal activity against Candida albicans MY1055 infected in DBA/2 mouse model assessed as log change in colony forming units in kidney at 25 mg/kg, po bid for 2 days and measured after 4 days by TOKA	Candida albicans	19	ALA4725308	organism-based format	Scientific Literature
9.	ALA4727382	Functional	Antifungal activity against Candida glabrata MY1381 assessed as fungal growth inhibition	Nakaseomyces glabratus	1	ALA4725308	organism-based format	Scientific Literature
10.	ALA4727383	Functional	Antifungal activity against Candida krusei ATCC 6258 assessed as fungal growth inhibition	Pichia kudriavzevii	1	ALA4725308	organism-based format	Scientific Literature
11.	ALA4727384	Functional	Antifungal activity against Candida tropicalis MY1012 assessed as fungal growth inhibition	Candida tropicalis	1	ALA4725308	organism-based format	Scientific Literature
12.	ALA4727385	Functional	Antifungal activity against Clavispora lusitaniae MY1396 assessed as fungal growth inhibition	Clavispora lusitaniae	1	ALA4725308	organism-based format	Scientific Literature
13.	ALA4727386	Functional	Antifungal activity against Candida parapsilosis ATCC 22019 assessed as fungal growth inhibition	Candida parapsilosis	1	ALA4725308	organism-based format	Scientific Literature
14.	ALA4727387	ADME	Clearance in mouse	Mus musculus	1	ALA4725308	organism-based format	Scientific Literature
15.	ALA4727388	ADME	Half lie in mouse	Mus musculus	1	ALA4725308	organism-based format	Scientific Literature
16.	ALA4727389	ADME	Clearance in rat	Rattus norvegicus	1	ALA4725308	assay format	Scientific Literature
17.	ALA4727390	ADME	Half life in rat	Rattus norvegicus	1	ALA4725308	assay format	Scientific Literature
18.	ALA4727391	ADME	AUC in po dosed rat	Rattus norvegicus	1	ALA4725308	organism-based format	Scientific Literature
19.	ALA4727392	ADME	Oral bioavailability in rat	Rattus norvegicus	1	ALA4725308	organism-based format	Scientific Literature
20.	ALA4727393	ADME	Clearance in dog	Canis lupus familiaris	1	ALA4725308	assay format	Scientific Literature